Firms

Alexandria Venture Investments

26 North Euclid Avenue, Pasadena, California 91101, United States

signal.nfx.com

are.com

alexandrialaunchlabs.com

investor.are.com

Alexandria Venture Investments is the strategic corporate venture platform of Alexandria Real Estate Equities, Inc., established in 1996. The parent’s current website also presents the platform as Alexandria Ventures®. SEC parent filings explicitly identify Alexandria Venture Investments, LLC as a Delaware subsidiary. This retained venture profile is distinct from the operating REIT, real-estate partnerships, individual principals and undisclosed transaction-specific affiliates. Parent real-estate ownership or tenancy alone does not establish a venture cash investment. The current published venture-linked leadership includes founder Joel S. Marcus; Hallie E. Kuhn and Jenna Foger, who co-lead Life Science and manage venture activities; and Blake L. Stevens, whose explicitly published investment remit covers Research Triangle portfolio oversight and the national agtech strategy. Blake’s regional role is retained without inventing an overall third co-lead title. Onn C. Lee’s shared corporate accounting function expressly includes the venture investment portfolio and is identified as support rather than a separate investment partner. January 2026 promotions are month-only facts, with exact role dates left unknown. Other parent directors and property executives are not automatically assigned to this unit. It invests from seed through growth in life sciences, diagnostics, research tools, agtech and enabling technology. Primary examples establish direct relevance to AI and neuroscience: BigHat’s September 2026 financing names Alexandria and describes AI protein design; Iambic’s November 2025 financing names Alexandria and describes AI discovery/development; QurAlis’ original 2018 seed announcement identifies Alexandria in ALS therapeutics; and the manager’s 2019 release establishes a seed investment in Holobiome’s nervous-system microbiome programme. These are source-qualified research and investment relationships, not independent clinical efficacy or regulatory approval findings. Its seed-capital programme was announced as a USD10–25 million target in 2016, formally launched as the Seed Capital Platform in January 2018, and is currently presented as the Alexandria Strategic Capital Platform. These sources establish a functioning co-investment programme and advisory framework, rather than proving a separately closed pooled LP vehicle or an exact paid-in fundraising total. The roughly USD1.5 billion reported under management, December 2022 adjusted cost basis of USD1.2 billion and unrealized gains of USD506 million are distinct portfolio/accounting metrics. Parent bond offerings, market capitalization and real-estate financing are not fund cash closes of this unit. No unsupported LP fundraising record is created.

Founded: 1996
Type: Venture capital

Funds0

No funds on record yet.

Team

Operations and support

Blake L. StevensResearch Triangle venture portfolio oversight and national agtech investment strategy; shared parent EVP – Regional Market Director

Hallie E. KuhnExecutive Vice President – Capital Markets and Co-Lead – Life Science

Jenna FogerExecutive Vice President – Co-Lead – Life Science

Joel S. MarcusFounder and leader, Alexandria Venture Investments; shared parent Executive Chairman

Onn C. LeeShared parent Executive Vice President – Accounting, including venture investment portfolio

Co-investing

ARCH Venture Partners

8VC

Casdin Capital

Eli Lilly and Company

Gaingels

Investments

$122M2026-05-14	Create Medicines	ARCH Venture Partners, 8VC, Alexandria Venture Investments, Newpath Partners
$40M2026-04	Alloy Therapeutics	Alex Kolicich, Founders Fund, 8VC, Alexandria Venture Investments, Gaingels, Thiel Capital, Echo
$50M2026-01-27	TRexBio	Eli Lilly and Company, SV Health Investors, Johnson & Johnson Innovation – JJDC, Pfizer Ventures, Alexandria Venture Investments, Polaris Partners, Delos Capital, Avego BioScience Capital, Janus Henderson Investors
$91M2026-01-13	Proxima Bio	DCVC, Jason Pontin, Modi Ventures, Magnetic Ventures, NVentures, Braidwell LP, Roivant Sciences, AIX Ventures, Yosemite, Alexandria Venture Investments
$122M2026	Create Medicines	ARCH Venture Partners, 8VC, Alexandria Venture Investments, Newpath Partners
$40M2026	Alloy Therapeutics	Founders Fund, 8VC, Alexandria Venture Investments, Gaingels, Thiel Capital, Echo
$216M2025-07-23	Dispatch Bio	ARCH Venture Partners, Alexandria Venture Investments, Stanford University, Bristol Myers Squibb
$216M2025-07-23	Dispatch Biotherapeutics	ARCH Venture Partners, Alexandria Venture Investments, Stanford University, Bristol Myers Squibb
$350M2025-02-26	Eikon Therapeutics	General Catalyst, T. Rowe Price, Alexandria Venture Investments, StepStone Group, Soros Fund Management, UC Investments, Lux Capital
$250M2025	Mirador Therapeutics	ARCH Venture Partners, Alexandria Venture Investments, Logos Capital, Farallon Capital Management, Sanofi Ventures, Venrock Healthcare Capital Partners
$84M2024-11-13	TRexBio	Delos Capital, Eli Lilly and Company, SV Health Investors, Johnson & Johnson Innovation – JJDC, Pfizer Ventures, Alexandria Venture Investments, Polaris Partners, Avego BioScience Capital, Agent Capital
$100M2024-04-30	Enlaza Therapeutics	J.P. Morgan Private Capital Life Sciences, Pappas Capital, Bregua Corporation, Alexandria Venture Investments, Avalon Ventures, Lightspeed Venture Partners, Samsara BioCapital, Amgen Ventures, Frazier Life Sciences, Regeneron Ventures
$400M2024-03-21	Mirador Tx	ARCH Venture Partners, Fidelity Management & Research Company, Alexandria Venture Investments, Logos Capital, Sanofi Ventures, Blue Owl Healthcare Opportunities
$60M2024-01-03	Remix Therapeutics	ARCH Venture Partners, Casdin Capital, Atlas Venture, Alexandria Venture Investments, W.T.T. Investment Ltd., Surveyor Capital
$95M2023-12-18	Neurogene	EcoR1 Capital, Redmile Group, Samsara BioCapital, Janus Henderson Investors, BlackRock, Casdin Capital, Avidity Partners, Cormorant Asset Management, Alexandria Venture Investments, Great Point Partners
$213M2023-12-12	Tome Biosciences	ARCH Venture Partners, Alexandria Venture Investments, GV, Polaris Partners, Longwood Fund, FUJIFILM Corporation
$45M2023-11-21	Alto Neuroscience	What If Ventures, Windham Capital Partners, Alpha Wave Global, Franklin Templeton, Eli Lilly and Company, Alexandria Venture Investments, Lightswitch Capital
$58M2023-09-12	Arialys Therapeutics	Johnson & Johnson Innovation – JJDC, Alexandria Venture Investments, Avalon BioVentures, Catalys Pacific, MPM BioImpact
$145M2023-06-07	Bitterroot Bio	ARCH Venture Partners, Alexandria Venture Investments, GV, Koch Disruptive Technologies, Deerfield
$73M2023-05-18	Myeloid Therapeutics	ARCH Venture Partners, 8VC, Alexandria Venture Investments, Moore Strategic Ventures, Primary Venture Partners, Newpath Partners
$270M2023-04-26	Orbital Therapeutics	ARCH Venture Partners, Casdin Capital, Alexandria Venture Investments, Andreessen Horowitz, Moore Strategic Ventures, Newpath Partners, Vineeta Agarwala
$—2023-02-28	Paratus Sciences	ARCH Venture Partners, Leaps by Bayer, Alexandria Venture Investments, Polaris Partners, BECO Capital, ClavystBio
$40M2023-02-06	IGGENIX	Khosla Ventures, Alexandria Venture Investments, Eli Lilly and Company, Global Brain Corporation, Samir Kaul
$121M2023	Seismic Therapeutic	Lightspeed, Alexandria Venture Investments, GV, Gaingels, Alphabet Inc., Boxer Capital, Bessemer Venture Partners
$75M2023	Georgiamune	General Catalyst, Catalio Capital Management, Alexandria Venture Investments, Mubadala Ventures
$145M2023	Bitterroot	ARCH Venture Partners, Alexandria Venture Investments, GV, Koch Disruptive Technologies, Deerfield
$168M2022-10-13	Odyssey Therapeutics	General Catalyst, Catalio Capital Management, Redpoint Ventures, T. Rowe Price, Alexandria Venture Investments, Colt Ventures
$147M2022-05-09	Aspen Neuroscience	ARCH Venture Partners, Mirae Asset, EDBI, Alexandria Venture Investments, S32, Lifeforce Capital
$76M2022-04-26	Pheast Therapeutics	ARCH Venture Partners, Catalio Capital Management, Alexandria Venture Investments
$85M2022-03-08	TRexBio	Eli Lilly and Company, SV Health Investors, Johnson & Johnson Innovation – JJDC, Pfizer Ventures, Alexandria Venture Investments, Polaris Partners, Laurion Capital Management
$15M2021-11-18	Fountain Therapeutics	Khosla Ventures, Alexandria Venture Investments, Eli Lilly and Company
$55M2021-10-26	Mozart Therapeutics	ARCH Venture Partners, MRL Ventures Fund, Leaps by Bayer, Alexandria Venture Investments, Altitude Life Science Ventures, Sofinnova Partners
$—2021-10-07	Neumora Therapeutics, Inc.	ARCH Venture Partners, Catalio Capital Management, F-Prime Capital, Alexandria Venture Investments, Polaris Innovation Fund, re.Mind Capital
$108M2021-09-01	Asher Bio	Y Combinator, Wellington Management, Alexandria Venture Investments, Logos Capital, Third Rock Ventures, Mission BioCapital
$25M2021-07-27	IGGENIX	Khosla Ventures, ShangBay Capital, Alexandria Venture Investments, Global Brain Corporation, Samir Kaul
$75M2021-04-02	Alloy Therapeutics	8VC, Presight Capital, Peter Thiel, Mubadala Capital, Founders Fund, Gaingels, Luma Bio-IT, Alexandria Venture Investments, Ulysses Diversified Holdings
$75M2021-01-27	Encodia	ARCH Venture Partners, Tao Capital Partners, Northpond Ventures, Alexandria Venture Investments, GV, Decent Capital
$7M2021-01-01	NextVivo	Khosla Ventures, Vinod Khosla, Alexandria Venture Investments
$7M2021	NextVivo	Khosla Ventures, Alexandria Venture Investments
$75M2021	Alloy Therapeutics	Founders Fund, 8VC, Alexandria Venture Investments, Gaingels, Mubadala Ventures, Presight Capital
$115M2020-12-16	Neurogene	EcoR1 Capital, Redmile Group, Samsara BioCapital, Cormorant Asset Management, BlackRock, Janus Henderson Investors, Casdin Capital, Avidity Partners, Alexandria Venture Investments
$81M2020-12-08	Remix Therapeutics	ARCH Venture Partners, Atlas Venture, Alexandria Venture Investments, Foresite Capital, The Column Group
$76M2020-06-09	Autobahn Therapeutics	ARCH Venture Partners, Alexandria Venture Investments, Bristol Myers Squibb, BVF Partners L.P., Cowen Healthcare Investments, Samsara BioCapital
$6M2019-12-12	Aspen Neuroscience	ARCH Venture Partners, Alexandria Venture Investments, S32, Axon Partners Group, OrbiMed, Domain Associates, Section 32
$28M2019-07-09	Aitia	The Cigna Group Ventures, Amgen Ventures, Celgene, Echo Health Ventures, Alexandria Venture Investments, Merck Global Health Innovation Fund, Gary Loveman
$104M2019-06-26	Encoded Therapeutics	ARCH Venture Partners, Venrock, Menlo Ventures, Alexandria Venture Investments, Illumina Ventures, RTW Investments, LP
$82M2019-04-30	Vividion Therapeutics	ARCH Venture Partners, Casdin Capital, Mirae Asset, Alexandria Venture Investments, Mubadala Ventures, Celgene
$82M2019-03-18	Karuna Therapeutics	ARCH Venture Partners, Fidelity Management & Research Company, Alexandria Venture Investments, Eventide Asset Management, Partner Fund Management, Pivotal bioVenture Partners, Sands Capital
$60M2019-01-30	Dewpoint Therapeutics	Polaris Partners, Samsara BioCapital, 6 Dimensions Capital, Alexandria Venture Investments, Leaps by Bayer, EcoR1 Capital
$40M2018-09-11	OncoResponse, Inc.	ARCH Venture Partners, Alexandria Venture Investments, Canaan Partners, Qatar Investment Authority, Redmile Group, RiverVest Venture Partners
$40M2018-09-11	OncoResponse	ARCH Venture Partners, Alexandria Venture Investments, Canaan Partners, Qatar Investment Authority, Redmile Group, RiverVest Venture Partners
$31M2018-08-14	Magnolia Neurosciences	ARCH Venture Partners, Alexandria Venture Investments, AbbVie, Eli Lilly and Company, Partnership Fund for New York City, Pfizer Ventures
$45M2018-05-15	Nohla Therapeutics	ARCH Venture Partners, Fidelity Management & Research Company, Alexandria Venture Investments, Celgene, Premier Partners
$—2018-04-05	QurAlis	Amgen Ventures, MP Healthcare Venture Management, Alexandria Venture Investments
$76M2017-11-29	Codiak Biosciences	ARCH Venture Partners, Casdin Capital, Alexandria Venture Investments, Alaska Permanent Fund Corporation, BECO Capital, Ona Capital
$55M2017-09-18	LifeMine Therapeutics	ARCH Venture Partners, MRL Ventures Fund, Alexandria Venture Investments, GV, WuXi AppTec, Boyu Capital
$—2016-11-29	Nohla Therapeutics	ARCH Venture Partners, Alexandria Venture Investments
$48M2016-01-06	Petra Pharma	ARCH Venture Partners, Alexandria Venture Investments, AbbVie, Eli Lilly and Company, Partnership Fund for New York City, Pfizer Ventures
$80M2015-11-17	Codiak Biosciences	ARCH Venture Partners, Alexandria Venture Investments, Fidelity Investments, Flagship Pioneering, Primary Venture Partners, Alaska Permanent Fund Corporation
$6MUnknown date	Ubiq	Y Combinator, Alexandria Venture Investments, TenOneTen Ventures, Okapi Venture Capital
$100MUnknown date	Enlaza Therapeutics	Lightspeed, Alexandria Venture Investments, Samsara BioCapital, Pappas Capital, Amgen Ventures, Avalon Capital Group
$100MUnknown date	Enlaza	Lightspeed, Alexandria Venture Investments, Frazier Healthcare Partners, Pappas Capital, Amgen Ventures, Avalon Capital Group
$40MUnknown date	Alloy Therapeutics	Founders Fund, 8VC, Thiel Capital, Alexandria Venture Investments, Gaingels, Echo
$40MUnknown date	Alloy Therapeutics	Founders Fund, 8VC, Thiel Capital, Alexandria Venture Investments, Gaingels, Echo
$61MUnknown date	Codiak Biosciences	ARCH Venture Partners, Alexandria Venture Investments, Fidelity Investments, Alaska Permanent Fund Corporation
$10MUnknown date	Boragen	ARCH Venture Partners, Alexandria Venture Investments, Flagship Pioneering, Pappas Capital, Mountain Group Partners, Syngenta Group Ventures
$50MUnknown date	ImmuneID	ARCH Venture Partners, Alexandria Venture Investments, Xfund, In-Q-Tel, Longwood Fund, Tekla Capital Management
$82MUnknown date	Vividion	ARCH Venture Partners, Casdin Capital, Mirae Asset, Alexandria Venture Investments, Mubadala Ventures, Celgene
$72MUnknown date	Rome	ARCH Venture Partners, Casdin Capital, Mirae Asset, Alexandria Venture Investments, Y Combinator, Sanofi Ventures, Mass General Brigham Ventures
$60MUnknown date	AiRNA	ARCH Venture Partners, +ND Capital, Alexandria Venture Investments, Forbion, Ono Venture Investment
$155MUnknown date	AiRNA	ARCH Venture Partners, +ND Capital, Alexandria Venture Investments, Forbion, Venrock Healthcare Capital Partners, Nextech Invest Ltd.
$65MUnknown date	Metacrine	ARCH Venture Partners, Franklin Templeton, Alexandria Venture Investments, Polaris Partners, venBio, Venrock Healthcare Capital Partners
$125MUnknown date	SonoThera	ARCH Venture Partners, Leaps by Bayer, Alexandria Venture Investments, Duquesne Family Office, Illumina Ventures, Vertex Ventures HC